The accounting information associated with clinical results is able to map the real cost efficiency in the clinical trial. The study analyzes explicitly the clinical trial carried out in 2017 by the "Bambin Gesù" Pediatric Hospital in Rome (Italy). The survey for the first time classifies the costs of a clinical trial on the use of micafungin in pediatric patients. The study provides an example of ways and items of expenses related to the clinical trial. The methodology used is applicable and can be used to compare future trials, thus identifying reference benchmarks. The study through practical application seeks to identify the correct method to avoid errors during the detection of clinical trials as evidenced by the study by Graves et al. (2002) through a proper application. The article also highlights the main cost items to be kept under control during the clinical trial phases. Moreover, given the incidence of candida in children, the study increases the literature on the administration and testing of specific drugs for treatment and therapy

Managerial Innovation in Hospitals: An Analysis of Adoption of Micro Costing

Secinaro Silvana;Radwan Maha;Brescia Valerio;Biancone Paolo
2019-01-01

Abstract

The accounting information associated with clinical results is able to map the real cost efficiency in the clinical trial. The study analyzes explicitly the clinical trial carried out in 2017 by the "Bambin Gesù" Pediatric Hospital in Rome (Italy). The survey for the first time classifies the costs of a clinical trial on the use of micafungin in pediatric patients. The study provides an example of ways and items of expenses related to the clinical trial. The methodology used is applicable and can be used to compare future trials, thus identifying reference benchmarks. The study through practical application seeks to identify the correct method to avoid errors during the detection of clinical trials as evidenced by the study by Graves et al. (2002) through a proper application. The article also highlights the main cost items to be kept under control during the clinical trial phases. Moreover, given the incidence of candida in children, the study increases the literature on the administration and testing of specific drugs for treatment and therapy
2019
8
7
87
93
http://www.ijmsbr.com/publications-of-ijmsbr/article/595/
clinical trial; micro-costing approach; micafungin; pediatric
Secinaro Silvana; Verardi Giovanni Paride; Radwan Maha; Gentili Cristina; Stola Giulia; Auriti Cinzia; Goffredo Bianca Maria; Antenucci Valeria; Brescia Valerio; Biancone Paolo
File in questo prodotto:
File Dimensione Formato  
Journal-3.pdf

Accesso aperto

Tipo di file: PDF EDITORIALE
Dimensione 577.25 kB
Formato Adobe PDF
577.25 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2318/1708894
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact